These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

115 related articles for article (PubMed ID: 2196259)

  • 21. Isolation of an aminoglycoside hypersensitive mutant and its application in screening.
    Numata K; Yamamoto H; Hatori M; Miyaki T; Kawaguchi H
    J Antibiot (Tokyo); 1986 Jul; 39(7):994-1000. PubMed ID: 3531132
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Enhanced active efflux, repression of porin synthesis and development of Mar phenotype by diazepam in two enterobacteria strains.
    Tavío MM; Vila J; Perilli M; Casañas LT; Maciá L; Amicosante G; Jiménez de Anta MT
    J Med Microbiol; 2004 Nov; 53(Pt 11):1119-1122. PubMed ID: 15496390
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Loss of hypermucoviscosity and increased fitness cost in colistin-resistant Klebsiella pneumoniae sequence type 23 strains.
    Choi MJ; Ko KS
    Antimicrob Agents Chemother; 2015 Nov; 59(11):6763-73. PubMed ID: 26282408
    [TBL] [Abstract][Full Text] [Related]  

  • 24. The effect of amikacin and imipenem alone and in combination against an extended-spectrum beta-lactamase-producing Klebsiella pneumoniae strain.
    Máthé A; Szabó D; Anderlik P; Rozgonyi F; Nagy K
    Diagn Microbiol Infect Dis; 2007 May; 58(1):105-10. PubMed ID: 17300908
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Activity of Ceftazidime-Avibactam Against Clinical Isolates of Klebsiella pneumoniae, Including KPC-Carrying Isolates, Endemic to New York City.
    Manning N; Balabanian G; Rose M; Landman D; Quale J
    Microb Drug Resist; 2018; 24(1):35-39. PubMed ID: 28590820
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Synergistic activity of synthetic N-terminal peptide of human lactoferrin in combination with various antibiotics against carbapenem-resistant Klebsiella pneumoniae strains.
    Morici P; Florio W; Rizzato C; Ghelardi E; Tavanti A; Rossolini GM; Lupetti A
    Eur J Clin Microbiol Infect Dis; 2017 Oct; 36(10):1739-1748. PubMed ID: 28470337
    [TBL] [Abstract][Full Text] [Related]  

  • 27. [Aminoglycosides and colistin inhibit biofilm formation in Klebsiella pneumoniae].
    Hostacká A; Ciznár I
    Epidemiol Mikrobiol Imunol; 2008 Aug; 57(3):101-5. PubMed ID: 18767377
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Aminoglycoside resistance in clinical Escherichia coli and Klebsiella pneumoniae isolates from Western Norway.
    Lindemann PC; Risberg K; Wiker HG; Mylvaganam H
    APMIS; 2012 Jun; 120(6):495-502. PubMed ID: 22583362
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Serum sensitivity and cell surface hydrophobicity of Klebsiella pneumoniae treated with gentamicin, tobramycin and amikacin.
    Hostacká A
    J Basic Microbiol; 1998; 38(5-6):383-8. PubMed ID: 9871334
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Aminoglycoside therapy for childhood urinary tract infection due to extended-spectrum β-lactamase-producing Escherichia coli or Klebsiella pneumoniae.
    Han SB; Lee SC; Lee SY; Jeong DC; Kang JH
    BMC Infect Dis; 2015 Oct; 15():414. PubMed ID: 26464143
    [TBL] [Abstract][Full Text] [Related]  

  • 31. In vitro efficacy of Bay k 4999, a new ureido-penicillin, in combination with aminoglycosides against Pseudomonas aeruginosa, Escherichia coli, Klebsiella pneumoniae and Proteus strains.
    Daschner FD; Steffens A; Langmaack H
    Chemotherapy; 1979; 25(5):282-5. PubMed ID: 113178
    [TBL] [Abstract][Full Text] [Related]  

  • 32. In vitro antibacterial activity of fosfomycin combined with other antimicrobials against KPC-producing Klebsiella pneumoniae.
    Yu W; Shen P; Bao Z; Zhou K; Zheng B; Ji J; Guo L; Huang C; Xiao Y
    Int J Antimicrob Agents; 2017 Aug; 50(2):237-241. PubMed ID: 28648647
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Discovery of anti-mucoviscous activity of rifampicin and its potential as a candidate antivirulence agent against hypervirulent Klebsiella pneumoniae.
    Namikawa H; Oinuma KI; Sakiyama A; Tsubouchi T; Tahara YO; Yamada K; Niki M; Takemoto Y; Miyata M; Kaneko Y; Shuto T; Kakeya H
    Int J Antimicrob Agents; 2019 Aug; 54(2):167-175. PubMed ID: 31173862
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Aminoglycosides against carbapenem-resistant Enterobacteriaceae in the critically ill: the pitfalls of aminoglycoside susceptibility.
    Zavascki AP; Klee BO; Bulitta JB
    Expert Rev Anti Infect Ther; 2017 Jun; 15(6):519-526. PubMed ID: 28375030
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Synergistic antibiotic combinations for colistin-resistant Klebsiella pneumoniae.
    Kádár B; Kocsis B; Tóth Á; Damjanova I; Szász M; Kristóf K; Nagy K; Szabó D
    Acta Microbiol Immunol Hung; 2013 Jun; 60(2):201-9. PubMed ID: 23827751
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Prevalence of Aminoglycoside-Modifying Enzymes in Escherichia coli and Klebsiella pneumoniae Producing Extended Spectrum β-Lactamases Collected in Two Multicenter Studies in Spain.
    Fernández-Martínez M; Ruiz Del Castillo B; Lecea-Cuello MJ; Rodríguez-Baño J; Pascual Á; Martínez-Martínez L;
    Microb Drug Resist; 2018 May; 24(4):367-376. PubMed ID: 29727265
    [TBL] [Abstract][Full Text] [Related]  

  • 37. [Aminoglycoside resistance of enterobacteria isolated from urinary infections in surgical departments].
    Muntean D; Licker M; Berceanu-Văduva D; Crăciunescu M; Hogea E; Popa M; Adămut M; Rădulescu M; Moldovan R
    Bacteriol Virusol Parazitol Epidemiol; 2008; 53(2):99-102. PubMed ID: 19856848
    [TBL] [Abstract][Full Text] [Related]  

  • 38. [Bacterial resistance in clinical isolates of Klebsiella pneumoniae].
    Wang YQ; Wang F; Zhu DM
    Zhonghua Yi Xue Za Zhi; 1995 Feb; 75(2):88-91, 126. PubMed ID: 7767775
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Aminoglycosides for Treatment of Bacteremia Due to Carbapenem-Resistant Klebsiella pneumoniae.
    Shields RK; Clancy CJ; Press EG; Nguyen MH
    Antimicrob Agents Chemother; 2016 May; 60(5):3187-92. PubMed ID: 26926642
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Effect of capsular polysaccharide of Klebsiella pneumoniae on host resistance to bacterial infections. I. Induction of increased susceptibility to infections in mice.
    Kato N; Kato O; Nakashima I
    Jpn J Microbiol; 1976 Jun; 20(3):163-72. PubMed ID: 9528
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.